S. 4741 · 118th Congress (2023–2025)
PLASMA Act
A bill to amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.
CRS summary not yet available.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 4741’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Thomas Tillis (R-NC)
- Cosponsors
3 cosponsors
1 original · 2 later
- Sen. Mark Kelly (D-AZ)· Original · Jul 23, 2024
- Sen. Marsha Blackburn (R-TN)· Later · Aug 1, 2024
- Sen. Alex Padilla (D-CA)· Later · Aug 1, 2024
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Finance.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (3)
PLASMA Act
Display title, Short title · Introduced in Senate
Preserving Life-saving Access to Specialty Medicines in America Act
Short title · Introduced in Senate
A bill to amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.
Official title · Introduced in Senate